Joseph Chao, MD | Authors


Microsatellite Instability Serves as a Predictive Biomarker of Response to Pembrolizumab

January 26, 2020

Joseph Chao, MD, discusses the importance of assessing the microsatellite instability (MSI) status in patients with advanced gastric/gastroesophageal junction cancer based on findings from a comparative analysis of KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062.